Quarterly report pursuant to Section 13 or 15(d)

Financial Instruments - Fair Value, Liabilities Measured on Recurring Basis (Details)

v3.24.3
Financial Instruments - Fair Value, Liabilities Measured on Recurring Basis (Details) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Liabilities    
Contingent consideration $ 2,600  
Fair Value, Recurring    
Liabilities    
Contingent consideration 2,600 $ 2,462
Fair Value, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Liabilities    
Contingent consideration 0 0
Fair Value, Recurring | Significant Other Observable Inputs (Level 2)    
Liabilities    
Contingent consideration 0 0
Fair Value, Recurring | Significant Unobservable Inputs (Level 3)    
Liabilities    
Contingent consideration $ 2,600 $ 2,462